Browse > Article
http://dx.doi.org/10.3904/kjm.2013.85.1.96

Precursor B-Cell Acute Lymphoblastic Leukemia in Two Patients with a History of Cytotoxic Therapy  

Shin, Suk Pyo (Department of Internal Medicine, CHA Bundang Medical Center, CHA University)
Song, Sang Hee (Department of Internal Medicine, CHA Bundang Medical Center, CHA University)
Ko, Eun Jung (Department of Internal Medicine, CHA Bundang Medical Center, CHA University)
Kim, Ji Su (Department of Internal Medicine, CHA Bundang Medical Center, CHA University)
Park, Chi Young (Department of Internal Medicine, CHA Bundang Medical Center, CHA University)
Oh, Doyeun (Department of Internal Medicine, CHA Bundang Medical Center, CHA University)
Chong, So Young (Department of Internal Medicine, CHA Bundang Medical Center, CHA University)
Publication Information
The Korean Journal of Medicine / v.85, no.1, 2013 , pp. 96-100 More about this Journal
Abstract
Therapy-related myeloid neoplasms have been well characterized. However, precursor B-cell acute lymphoblastic leukemia in patients with prior malignancies is uncommon, and the effect of prior cytotoxic therapy on development of precursor B-cell acute lymphoblastic leukemia is controversial. Therapy-related precursor B-cell acute lymphoblastic leukemia has been reported occasionally. However, cytotoxic therapy-related precursor B-cell acute lymphoblastic leukemia has been reported in Korea only rarely. We herein describe two cases of therapy-related precursor B-cell acute lymphoblastic leukemia.
Keywords
Precursor B-cell acute lymphoblastic leukemia; Cytotoxic therapy; Therapy-related leukemia;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Vardiman JW, Arber DA, Brunning RD, et al. Therapyrelated myeloid neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, Thiele J, Vardiman JW, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2008:127-129.
2 Shivakumar R, Tan W, Wilding GE, Wang ES, Wetzler M. Biologic features and treatment outcome of secondary acute lymphoblastic leukemia: a review of 101 cases. Ann Oncol 2008;19:1634-1638.   DOI   ScienceOn
3 Andersen MK, Christiansen DH, Jensen BA, Ernst P, Hauge G, Pedersen-Bjergaard J. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol 2001;114:539-543.   DOI   ScienceOn
4 Chen W, Wang E, Lu Y, Gaal KK, Huang Q. Therapyrelated acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review. Am J Clin Pathol 2010;133:75-82.   DOI   ScienceOn
5 Lee SG, Choi JR, Kim JS, Park TS, Lee KA, Song J. Therapy-related acute lymphoblastic leukemia with t(9;22) (q34;q11.2):a case study and review of the literature. Cancer Genet Cytogenet 2009;191:51-54.   DOI   ScienceOn
6 Cho J, Hur M, Moon HW, Yun YM, Lee CH, Lee HG. A case of therapy-related ALL with MLL gene rearrangement following treatment of breast cancer. Korean J Lab Med 2010;30:255-259.   DOI   ScienceOn
7 Yoo BJ, Nam MH, Sung HJ, et al. A case of therapy-related acute lymphoblastic leukemia with t(11;19)(q23;p13.3) and MLL/MLLT1 gene rearrangement. Korean J Lab Med 2011; 31:13-17.   DOI   ScienceOn
8 Shim H, Chi HS, Jang S, et al. Therapy-related acute leukemia in breast cancer patients: twelve cases treated with a topoisomerase inhibitor. Korean J Hematol 2010;45:177-182.   DOI   ScienceOn
9 Tang G, Zuo Z, Thomas DA, et al. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related? Haematologica 2012;97:919-925.   DOI
10 Pagano L, Pulsoni A, Tosti ME, et al. Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia: Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Br J Haematol 1999;106:1037-1040.   DOI   ScienceOn